[email protected]/(408) 457-3700

About Corhythm

Corhythm is an early stage company developing a novel therapy for the treatment of atrial fibrillation. More than three million Americans suffer from atrial fibrillation or a rapid, irregular heart rhythm. Atrial fibrillation is the most common cardiac arrhythmia and the leading cause of stroke and heart failure. While current therapies exist, none represent an ideal treatment due to limited efficacy and undesirable side effects.

You need to register as an accredited investor before we can show you the details of any investment opportunities.

VentureHealth is currently invite only.

Request An Invite!

Startup's Info

Location:
San Antonio
Markets:
Medical Devices, Digital Health
Therapeutic Areas:
Hematology, Vascular Diseases